Dr Cyrus S. Poonawalla receives 2nd Dr. K. Anji Reddy Memorial Fellowship

23 January 2025 | News

For extraordinary contributions to the advancement of the pharmaceutical and biopharmaceutical industries

The Institute of Chemical Technology (ICT Mumbai), under its flagship initiative, the Mumbai Biocluster, has awarded 2nd Dr. K. Anji Reddy Memorial Fellowship for Affordable Biopharmaceuticals to Dr Cyrus S. Poonawalla, Chairman, Serum Institute of India, a revolutionary entrepreneur, in recognition of his exceptional contributions to biopharmaceutical innovation and global healthcare.

Dr Cyrus S. Poonawalla’s extraordinary contributions to global healthcare have established India as a hub for affordable vaccines, saving billions of lives worldwide. As the visionary chairman of the Serum Institute of India, Dr Poonawalla has demonstrated how innovation and unwavering dedication can drive transformative change. His remarkable legacy, delivering over 1.5 billion vaccine doses annually to more than 170 countries, and his pivotal role in combating the COVID-19 pandemic stand as enduring testaments to his leadership and commitment to humanity.

Established by ICT Mumbai to honour the late Dr. K. Anji Reddy, founder of Dr. Reddy’s Laboratories, a visionary in Indian pharmaceuticals, the fellowship recognises individuals who have made extraordinary contributions to the advancement of the pharmaceutical and biopharmaceutical industries. The fellowship celebrates innovation, leadership and commitment to addressing global healthcare challenges.

The award was presented during a special ceremony at Pune, in the presence of Chief Guest Dr R. A. Mashelkar, a distinguished scientist and Padma Vibhushan awardee. The ceremony was jointly hosted by the Institute of Chemical Technology, Mumbai and the Ministry of Higher and Technical Education, Government of Maharashtra, represented by Professor Anniruddha B. Pandit, Vice Chancellor and Shri Chandrakant (Dada) Patil, Minister of Higher and Technical Education.

On the sidelines of the event Professor A. B. Pandit, Vice Chancellor, ICT Mumbai said, “Mumbai Biocluster is an organization that is going to be established on the premises of ICT. Currently, many drugs and medicines are manufactured using synthetic chemicals. However, producing them through natural methods can significantly reduce side effects. This groundbreaking research will take place within the Biocluster, with support from several leading pharmaceutical companies."

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account